Product
GB001
1 clinical trial
1 indication
Indication
HealthyClinical trial
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase IIa Clinical Trial to Evaluate the Efficacy and Safety of Oral Local Use of GB001 Recombinant Peptide Spray for the Treatment of Mild Recurrent Aphthous UlcerStatus: Active (not recruiting), Estimated PCD: 2023-12-06